Recent Research Articles
The business of cancer care is complex, and not always, shall we say, fair and transparent to patients … especially when it comes to treatment costs. This opaqueness is especially problematical when it comes to cancer therapies such as chemotherapy that are infused intravenously in a hospital or clinic. The decision-making process, through which standard of care drug(s) are recommended and ultimately prescribed, can cross a line that favors profit over true patient value.
New study published in Frontiers of Aging included over 2,000 healthy adults over 70, and tracked relative cancer risk over five years. Participants were randomized to receive variations of vitamin D, omega-3, and home exercise.
How do our lifestyle choices influence active cancer treatment, in terms of helping to mitigate various side effects or otherwise potentiate the efficacy of active treatment itself? New ASCO Guideline aims to inform oncologists to better support their patients.
According to a new study published in the Journal of Oncology, breast cancer patients treated in facilities offering integrative medicine support had better survival outcomes than patients treated in facilities that did not offer complementary treatment options.
Brown rice contains more inorganic arsenic than white rice. A new study reveals how to easily reduce the cumulative effect of inorganic arsenic for brown rice lovers around the planet.
MD Anderson’s integrative medicine chief Dr. Lorenzo Cohen shares critical insights on the troubling environmental stew we live in, what we know about its impact on cancer, and how best to limit our exposure.
Despite the remarkable progress in drug development across several populations of cancer, troubling facts have recently emerged about several expensive FDA-approved anticancer drugs.
Over the years I’ve coached many people who were determined to forego conventional cancer care—going against their oncologists’ recommendations, and often countering their partners’ and families’ opinions, too.
A recent investigation commissioned by the Environmental Working Group identified imazalil and thiabendazole on nearly 90 percent of non-organic citrus fruit samples.
Recent studies show approximately one in four blood cancer patients fail to produce detectable antibodies after COVID-19 vaccination. This is most prevalent in those hosting non-Hodgkin lymphomas and chronic lymphocytic leukemia, but also in those hosting multiple myeloma and other blood cancers.